British Association of Dermatologists Living Guideline for Managing People with Alopecia Areata 2025
November 2025
in “
British Journal of Dermatology
”
TLDR The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.
The British Association of Dermatologists' 2025 guideline for managing alopecia areata (AA) provides a comprehensive, evidence-based framework for treatment, emphasizing individualized care and patient involvement in decision-making. Key updates include the use of licensed oral Janus kinase inhibitors for severe AA in adults and children aged 12 and above, with a focus on long-term treatment to reduce relapse risk. The guideline also highlights the importance of psychological support, assessing quality of life, and addressing the emotional and functional impacts of AA. Recommendations cover various treatments, including corticosteroids and contact immunotherapy, while acknowledging the need for further research on safety, efficacy, and the development of biomarkers. The guideline is designed for practical use in the UK NHS and can be adapted for international healthcare systems.